Case Studies

SK BioPharmaceuticals

Small US biopharm subsidiary of SK Corporation of Korea seeking to out-license an anti-epileptic and anti-depressant in early clinical trials
Little or no experience with multi-national pharma
Sage developed IM and control sheet for an out-licensing program
Sage negotiated and closed licenses with J&J (Ortho-McNeil and Jannsen) with milestone value of each in excess of $90 million

Oxford UK – 19th April 2010 – Sense Proteomic Ltd. has announced the appointment of The Sage Group as its business development consultant to assist in expanding its global biomarker discovery partnerships. Sense is part of Ox...Read entire article

Cambridge UK and Clinton USA – December 2009 – The Sage Group is pleased to announce the appointment of two new seasoned Executive Directors – Dr. Tom Geimer in Australia and Dr. Laurence Shaw in Israel. Drs. Geimer and...Read entire article

Cambridge UK and Clinton USA – December, 2009 – The Sage Group, Inc. is pleased to announce the expansion of its global network with the opening of an Israeli office and the appointment of Dr. Laurence Shaw as Executive Direc...Read entire article

Contact Us

If you are interested in contacting us or obtaining the contact details for one of our offices, please use our contact page.

If you would like to make a more comprehensive business enquiry, you can send us further details of your company using our Business Enquiry Form.

Site by YouSoft Privacy Policy Contact us